Level Four Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,180
| Closed | -$333K | – | 664 |
|
|
2021
Q4 | $333K | Buy |
2,180
+21
| +1% | +$3.21K | 0.03% | 497 |
|
|
2021
Q3 | $349K | Sell |
2,159
-520
| -19% | -$84.1K | 0.04% | 358 |
|
|
2021
Q2 | $438K | Sell |
2,679
-64
| -2% | -$10.5K | 0.03% | 431 |
|
|
2021
Q1 | $413K | Sell |
2,743
-233
| -8% | -$35.1K | 0.03% | 422 |
|
|
2020
Q4 | $451K | Buy |
2,976
+147
| +5% | +$22.3K | 0.04% | 384 |
|
|
2020
Q3 | $383K | Sell |
2,829
-536
| -16% | -$72.6K | 0.03% | 394 |
|
|
2020
Q2 | $457K | Buy |
+3,365
| New | +$457K | 0.04% | 380 |
|
|
2020
Q1 | – | Sell |
-2,535
| Closed | -$305K | – | 519 |
|
|
2019
Q4 | $305K | Buy |
2,535
+270
| +12% | +$32.5K | 0.01% | 465 |
|
|
2019
Q3 | $225K | Sell |
2,265
-329
| -13% | -$32.7K | 0.02% | 453 |
|
|
2019
Q2 | $283K | Sell |
2,594
-489
| -16% | -$53.3K | 0.03% | 435 |
|
|
2019
Q1 | $345K | Buy |
3,083
+165
| +6% | +$18.5K | 0.04% | 378 |
|
|
2018
Q4 | $281K | Sell |
2,918
-1,152
| -28% | -$111K | 0.04% | 417 |
|
|
2018
Q3 | $496K | Buy |
4,070
+25
| +0.6% | +$3.05K | 0.05% | 343 |
|
|
2018
Q2 | $444K | Sell |
4,045
-930
| -19% | -$102K | 0.03% | 398 |
|
|
2018
Q1 | $531K | Buy |
4,975
+1,666
| +50% | +$178K | 0.04% | 350 |
|
|
2017
Q4 | $356K | Buy |
3,309
+171
| +5% | +$18.4K | 0.03% | 413 |
|
|
2017
Q3 | $349K | Buy |
3,138
+513
| +20% | +$57.1K | 0.03% | 388 |
|
|
2017
Q2 | $251K | Hold |
2,625
| – | – | 0.04% | 416 |
|
|
2017
Q1 | $251K | Sell |
2,625
-57
| -2% | -$5.45K | 0.03% | 454 |
|
|
2016
Q4 | $237K | Buy |
+2,682
| New | +$237K | 0.03% | 412 |
|